186 related articles for article (PubMed ID: 34893681)
1. Ileal microbial shifts after Roux-en-Y gastric bypass orchestrate changes in glucose metabolism through modulation of bile acids and L-cell adaptation.
Dang JT; Mocanu V; Park H; Laffin M; Tran C; Hotte N; Karmali S; Birch DW; Madsen K
Sci Rep; 2021 Dec; 11(1):23813. PubMed ID: 34893681
[TBL] [Abstract][Full Text] [Related]
2. The effect of distal-ileal exclusion after Roux-en-Y gastric bypass on glucose tolerance and GLP-1 response in type-2 diabetes Sprague-Dawley rat model.
Dolo PR; Li C; Zhu X; Yao L; Meng S; Hong J
Surg Obes Relat Dis; 2018 Oct; 14(10):1552-1560. PubMed ID: 30122358
[TBL] [Abstract][Full Text] [Related]
3. Takeda G Protein-Coupled Receptor 5-Mechanistic Target of Rapamycin Complex 1 Signaling Contributes to the Increment of Glucagon-Like Peptide-1 Production after Roux-en-Y Gastric Bypass.
Zhai H; Li Z; Peng M; Huang Z; Qin T; Chen L; Li H; Zhang H; Zhang W; Xu G
EBioMedicine; 2018 Jun; 32():201-214. PubMed ID: 29859856
[TBL] [Abstract][Full Text] [Related]
4. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
[TBL] [Abstract][Full Text] [Related]
5. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
6. Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats.
Bhutta HY; Rajpal N; White W; Freudenberg JM; Liu Y; Way J; Rajpal D; Cooper DC; Young A; Tavakkoli A; Chen L
PLoS One; 2015; 10(3):e0122273. PubMed ID: 25798945
[TBL] [Abstract][Full Text] [Related]
7. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
[TBL] [Abstract][Full Text] [Related]
9. Effects of Roux-en-Y gastric bypass and ileal transposition surgeries on glucose and lipid metabolism in skeletal muscle and liver.
Pezeshki A; Chelikani PK
Surg Obes Relat Dis; 2014; 10(2):217-28. PubMed ID: 24603111
[TBL] [Abstract][Full Text] [Related]
10. The effect of aging on glucose metabolism improvement after Roux-en-Y gastric bypass in type 2 diabetes rats.
Chen W; Yin H; Xiao J; Liu W; Qu Q; Gong F; He X
Nutr Diabetes; 2022 Dec; 12(1):51. PubMed ID: 36564376
[TBL] [Abstract][Full Text] [Related]
11. Peptide Tyrosine-Tyrosine Triggers GLP-2-Mediated Intestinal Hypertrophy After Roux-en-Y Gastric Bypass.
Pérez-Arana GM; Díaz-Gómez A; Camacho-Ramírez A; Ribelles-García A; Almorza-Gomar D; Gracia-Romero M; Prada-Oliveira JA
Obes Surg; 2022 Dec; 32(12):4023-4032. PubMed ID: 36301409
[TBL] [Abstract][Full Text] [Related]
12. Dual effect of RYGB on the entero-insular axis: How GLP-1 is enhanced by surgical duodenal exclusion.
Pérez-Arana GM; Díaz-Gómez A; Camacho-Ramírez A; Ribelles-García A; Almorza-Gomar D; Gracia-Romero M; Mateo-Gavira I; Castro-Santiago MJ; Casar-García J; Prada-Oliveira JA
Ann Anat; 2023 Aug; 249():152094. PubMed ID: 37011826
[TBL] [Abstract][Full Text] [Related]
13. Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery.
Jensen CZ; Bojsen-Møller KN; Svane MS; Holst LM; Hermansen K; Hartmann B; Wewer Albrechtsen NJ; Kuhre RE; Kristiansen VB; Rehfeld JF; Clausen TR; Holst JJ; Madsbad S
Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G661-G672. PubMed ID: 32068442
[TBL] [Abstract][Full Text] [Related]
14. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.
Albaugh VL; Banan B; Antoun J; Xiong Y; Guo Y; Ping J; Alikhan M; Clements BA; Abumrad NN; Flynn CR
Gastroenterology; 2019 Mar; 156(4):1041-1051.e4. PubMed ID: 30445014
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
16. Effects of Diet on Bile Acid Metabolism and Insulin Resistance in Type 2 Diabetic Rats after Roux-en-Y Gastric Bypass.
Shan CX; Qiu NC; Liu ME; Zha SL; Song X; Du ZP; Rao WS; Jiang DZ; Zhang W; Qiu M
Obes Surg; 2018 Oct; 28(10):3044-3053. PubMed ID: 29721762
[TBL] [Abstract][Full Text] [Related]
17. Vagal activation alters prandial bile acid composition and glycemia in patients with hypoglycemia after Roux-en-Y gastric bypass surgery.
Honka H; Bhattacharjee J; Zadeh M; Kohli R; Gastaldelli A; Salehi M
Neurogastroenterol Motil; 2024 May; 36(5):e14763. PubMed ID: 38342974
[TBL] [Abstract][Full Text] [Related]
18. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
Carmody JS; Muñoz R; Yin H; Kaplan LM
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
[TBL] [Abstract][Full Text] [Related]
19. Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.
Nielsen S; Svane MS; Kuhre RE; Clausen TR; Kristiansen VB; Rehfeld JF; Holst JJ; Madsbad S; Bojsen-Moller KN
Physiol Rep; 2017 Feb; 5(3):. PubMed ID: 28202805
[TBL] [Abstract][Full Text] [Related]
20. Roux-en-Y gastric bypass alters intestinal glucose transport in the obese Zucker rat.
Meng Q; Culnan DM; Ahmed T; Sun M; Cooney RN
Front Endocrinol (Lausanne); 2022; 13():901984. PubMed ID: 36034439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
